Biomedical Engineering Reference
In-Depth Information
278. Cho, E. J.; Yang, J.; Mohamedali, K. A.; Lim, E. K.; Kim, E. J.; Farhangfar, C. J.; Suh, J. S.;
Haam, S.; Rosenblum, M. G.; Y.M., H. Sensitive Angiogenesis Imaging of Orthotopic Bladder
Tumors in Mice Using a Selective Magnetic Resonance Imaging Contrast Agent Containing
VEGF121/rGel.
Invest. Radiol.
2011,
46,
441-449.
279. Koch, S.; Tugues, S.; Li, X.; Gualandi, L.; Claesson-Welsh, L. Signal Transduction by Vascu-
lar Endothelial Growth Factor Receptors.
Biochem. J.
2011,
437,
169-183.
280. Press, M. F.; Lenz, H. J. EGFR, HER2 and VEGF Pathways: Validated Targets for Cancer
Treatment.
Drugs
2007,
67,
2045-2075.
281. Shao, Y. Z.; Liu, L. Z.; Song, S. Q.; Cao, R. H.; Liu, H.; Cui, C. Y.; Li, X.; Bie, M. J.; Li, L. A
Novel One-step Synthesis of Gd3+-incorporated Mesoporous SiO
2
Nanoparticles for Use as
an Efficient MRI Contrast Agent.
Contrast Media Mol. Imaging
2011,
6,
110-118.
282. Jemal, A.; Siegel, R. W.; Xu, J.; Ward, E. Cancer Statistics.
Cancer J. Clin.
2010,
60,
277-300.
283. Meng, S.; Tripathy, D.; Frenkel, E. P.; Shete, S.; Naftalis, E. Z.; Huth, J. F., et al. Circulating
Tumor Cells in Patients with Breast Cancer Dormancy.
Clin. Cancer Res.
2004,
10,
8152-8162.
284. Peierga, J. Y.; Bonneton, C.; Vincetn-Salomon, A.; de Cremoux, P.; Nos, C.; Blin, N., et al.
Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital
Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients.
Clin. Cancer
Res.
2004,
10,
1392-1400.
285. Xu, H.; Aguilar, Z. P.; Yang, L.; Kuang, M.; Duan, H.; Xiong, Y.; Wei, H.; Wang, A. Y. Anti-
body Conjugated Magnetic Iron Oxide Nanoparticles for Cancer Cell Separation in Fresh
Whole Blood.
Biomaterials
2011,
32,
9758-9765.
286. Allard, W. J.; Matera, J.; Miller, M. C.; Repollet, M.; Connelly, M. C.; Rao, C., et al. Tumor
Cells Circulate in the Peripheral Blood of all Major Carcinomas but not in Healthy Subjects or
Patients with Nonmalignant Diseases.
Clin. Cancer Res.
2004,
10,
6897-6904.
287. Miltenyi, S.; Muller, W.; Weichel, W.; Radbruch, A. High Gradient Magnetic Cell Separation
with MACS.
Cytometry
1990,
11,
231-238.
288. Pamme, N.; Wilhelm, C. Continuous Sorting of Magnetic Cells Via On-chip Freeflow Magne-
tophoresis.
Lab Chip
2006,
6,
974-980.
289. Xu, R.
Particle Characterization: Light Scattering Methods
; Kluwer Academic Publishers:
Dordrecht, 2001.
290. Weissleder, R.; Kelly, K.; Sun, E. Y.; Shtatland, T.; Josephson, L. Cell-specific Targeting of
Nanoparticles by Multivalent Attachment of Small Molecules.
Nat. Biotechnol.
2005,
23,
1418-1423.
291. Decuzzi, P.; Pasqualini, R.; Arap, W.; Ferrari, M. Intravascular Delivery of Particulate Sys-
tems: Does Geometry Really Matter?
Pharm. Res.
2009,
26,
235-243.
292. Bautista, C. V.; Felis, C. P.; Espinet, J. M.; Garcia, J. B.; Salas, J. V. Telomerase Activity is a
Prognostic Factor for Recurrence and Survival in Rectal Cancer.
Dis. Colon Rectum
2007,
50,
611-620.
293. Spernyak, J. A.; White, W. H.; Ethirajan, M.; Patel, N. J.; Goswami, L.; Chen, Y. H.;
Turowski, S.; Missert, J. R.; Batt, C.; Mazurchuk, R.; Pandey, R. K. Hexylether Derivative of
Pyropheophorbide-a (HPPH) on Conjugating with 3gadolinium(III) Aminobenzyldiethylene-
triaminepentaacetic acid shows Potential for In vivo Tumor Imaging (MR, fluorescence) and
Photodynamic Therapy.
Bioconjugate Chem.
2010,
21,
828-835.
294. Xie, J.; Lee, S.; Chen, X. Nanoparticle-based Theranostic Agents.
Adv. Drug Deliv. Rev.
2010,
62,
1064-1079.
295. Namiki, Y.; Namiki, T.; Yoshida, H.; Ishii, Y.; Tsubota, A.; Koido, S.; Nariai, K.; Mitsunaga, M.;
Yanagisawa, S.; Kashiwagi, H.; Mabashi, Y.; Yumoto, Y.; Hoshin, S.; Fujise, K.; Tada, N. A
Novel Magnetic Crystal Lipid Nanostructure for Magnetically Guided In vivo Gene Delivery.
Nat. Nanotechnol.
2009,
4,
598-606.
